drugset / Trial / NCT00003020
LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases
Treatment
Summary
RATIONALE: LMB-7 immunotoxin can locate tumor cells and kill them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of LMB-7 immunotoxin in treating patients who have leptomeningeal metastases metastases.
Timeline
- Start
- 1997-09
- Primary completion
- 2000-09
- Completion
- 2000-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LMB-7 | Protein / enzyme biologic | — | Intrathecal |